Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 7.1% in the afternoon session after the company trimmed the upper ...

Analog Devices is at a turning point, with revenue and margin recovery underway after a challenging 2024. Click here to find ...

Also: A bipartisan plan to expand the home supply, an investment income strategy that lowers risk and advice from the ...